International Registry for Primary Hyperoxaluria

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2003-09-30

Study Completion Date

2009-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to collect medical information from a large number of patients in many areas of the world with primary hyperoxaluria. This medical information will be entered into a registry to help the investigators compare similarities and differences in patients and their symptoms. The more patients that the investigators are able to enter into the registry, the more the investigators will be able to understand primary hyperoxaluria and learn better ways of treating patients with this disease. It is the investigators hope that by entering as many patients with PH as possible, the information that the investigators collect may help physicians diagnose patients sooner and determine what treatments may work best on patients with similar medical or genetic backgrounds.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Rare Kidney Stone Consortium Patient Registry

NCT00588562

Primary Hyperoxaluria Dent Disease Cystinuria +1 more

RECRUITING

Oxalate Excretion Profile in Patients with a Heterozygous Mutation of the AGXT (alanine-glyoxylate Aminotransferase) Gene

NCT06283082

Hyperoxaluria (Disorder)

RECRUITING NA

Prospective Research Rare Kidney Stones (ProRKS)

NCT02780297

Hyperoxaluria Cystinuria Dent Disease +2 more

RECRUITING

Descriptive Analysis of Gut Microbiome Alterations in Hyperoxaluric Patients

NCT02794649

Oxalate, Primary Hyperoxaluria, Microbiome

UNKNOWN

Gut Kidney Axis in Enteric Hyperoxaluria

NCT05124886

Enteric Hyperoxaluria

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study involves the collection of medical information to create a computer database (registry) for patients with PH. The information will be entered into the registry by your physician, healthcare provider or a staff member of the Mayo Clinic Hyperoxaluria Center. The computer web site for the registry is secure and protected by a required password. Some information which will be entered may include your age at first symptoms of PH,kidney stone history, lab values, kidney function, and your health over time. Information for a patient can only be viewed by the appropriate physician and staff. Once the information is entered into the registry, you will only be identified by a code number.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Hyperoxaluria Nephrocalcinosis Kidney Stones

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PH Patients

Patients with:

Primary Hyperoxaluria Type I Primary Hyperoxaluria Type II Primary Hyperoxaluria NonI-NonII

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Liver biopsy or genetic analysis that confirms a diagnosis of hyperoxaluria
* In the absence of a liver biopsy:
* Urine oxalate excretion of \>0.8 mmol/1.73 m² /day without other causes such as enteric hyperoxaluria
* Family history of PH in a sibling will be supportive
* A history or current finding of kidney stones or nephrocalcinosis will be supportive
* An increase in urine glycolate may suggest PHI or an increase in urine L-glycerate may suggest PHII, though not required for diagnosis.
* Patients presenting in renal failure with an elevate pre-dialysis plasma oxalate of 60 umol/l and a kidney biopsy that confirms extensive oxalate deposition, or evidence of systemic oxalosis